Witness the birth of IKO! Xiaohulu opens the door and waits for you!
-
Last Update: 2016-09-13
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Speaking of ikosin, many mothers will think of pink, green and lovely little gourd In 1994, dyne pharmaceutical was officially established, and its mission is to "make millions of Chinese children healthy and strong" It has always focused on the research, development and production of children's health products In 2016, icoxin has accompanied Chinese babies for 20 years On this occasion, Shandong Rongcheng dyne factory, the birthplace of little gourd, will open to consumers for the first time Mothers will be invited to go into dyne, approach icoxin, get to know the whole process of production of little gourd, and experience the excellent quality of icoxin for 20 years! Then, what are the highlights of xiaohulu's family? Life experience: adapt to the market, keep pace with the times, in 1994, dyne pharmaceutical was established Under the leadership of general manager Yang Jie, the enterprise has come out of a development path with dyne characteristics in the fluctuating and stressful Chinese pharmaceutical market, and has become a leading enterprise focusing on children's health Dyne pharmaceutical's products include the well-known icoxin (vitamin AD drops), gedixin (compound calcium carbonate effervescent granules), iganxin (licorice zinc granules), etc In recent years, dyne pharmaceutical has begun to work in the field of children's products and children's food, and is still developing new products and enriching product lines, and will launch a series of mother and infant nutrition food and supplies Dyne pharmaceutical attaches great importance to scientific and technological innovation and research and development, and actively carries out research on customized children's drugs More than 60 children's drugs have been approved, involving research in the field of children's common diseases, frequently occurring diseases and some rare diseases, all of which are special specifications and dosage forms for children At the same time, we will make every effort to expand infrastructure construction and increase investment in technology and talents At the beginning of 2011, Dayin pharmaceutical industry established the first domestic research and Development Center for children's drug use technology, became a national comprehensive large platform for new drug research and development technology industrialization demonstration enterprise, and effectively provided a strong guarantee for the research and development innovation of children's special drugs In addition, it is also the only Xinhua news agency economic reference newspaper "children's medicine research base" in the industry, which perfectly explains the R & D concept of "customized children's medicine" Quality point of view: the factory directly attacks, witnessing the strict and sophisticated production equipment: IKO new adopts the most advanced production line and production process in the world, and the production equipment is the top equipment imported from Italy, Japan and South Korea In 2016, the production line passed the TGA certification (i.e the Australian drug administration certification, known as the world's most stringent production standard), and kept improving in all aspects of the production process to ensure product quality Unique patent technology: icoxin adopts the unique technology of capsule wall technology, which has won the national invention patent It can effectively reduce the light transmittance, retain more than 97% of the effective ingredients, avoid the oxidation failure caused by the unstable nature of vitamin AD and the special physical and chemical properties of light decomposition, and ensure the product quality and curative effect to the greatest extent High quality imported raw and auxiliary materials: IQC's vitamin A and d raw materials are from the top 20 industrial chemical enterprises in the world (DSM company in the Netherlands); the capsule skin is also made of high-quality gelatin raw materials produced by roseroth, a world-renowned multinational group with more than 100 years of gelatin research and development and production history Strict quality management system: iqxin's production process has the dynamic control of the highest standard quality management system - high quality raw material selection, strict process control, finished product release standard higher than the legal standard, and the most authoritative monitoring instrument Ensure the quality of each IKO Closed purification workshop: the production environment of ikxin is carried out in strict accordance with GMP requirements and fully meets the requirements of class D clean area The closed purification workshop completely avoids any risk of pollution Highlight of glory: adhere to the mission and make brilliant achievements Icoxin vitamin AD drop is a kind of medicine brand-name nutritional supplement aiming at the high rate of vitamin A and D deficiency of 0-3-year-old infants in China It takes one pill every day from the 15th day of the baby's birth and continuously takes it to the age of 3 years It can effectively prevent and treat vitamin A and vitamin D deficiency and effectively solve the two major health problems faced by Chinese infants In addition, ikosin uses single dose of capsule wall packaging, unique light avoiding technology, and vitamin A and D are strictly in accordance with the scientific ratio of 3:1, more scientific to meet the nutritional needs of infants In the past 20 years since its launch, icoxin has been recognized and praised by tens of millions of consumers and medical workers with its excellent product quality and good efficacy Over the years, icoxin has always maintained a high-speed sales growth, becoming a leading brand of similar products, and its market share ranks first In recent years, it is not an accident that IQC has successively won important awards from authoritative medical institutions and industry media It is the inevitable result of the high recognition of IQC quality by consumers, medical workers and the pharmaceutical industry It is also a strong proof of the great mission of dyne pharmaceutical industry to "make millions of Chinese children healthy and strong" In the future, dyne pharmaceutical will spare no effort to strive for the development of China's pediatric medicine industry!
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.